Company Monitoring Page for Incyte

latest headlines for company on cafepharma

Incyte and AstraZeneca Announce New Lung Cancer Clinical Trial Collaboration
Yahoo
Mon, 01/11/16 - 08:34 am
Tags:
Incyte, AstraZeneca, lung cancer, clinical trials, INCB39110, JAK inhibitors
Feuerstein's Heroes and Zeroes of Biotech Investing in 2015
Yahoo/TheStreet.com
Mon, 01/4/16 - 09:20 am
Tags:
biotech, Sprout Pharmaceuticals, Addyi, Novartis, Entresto, Hillary Clinton, Regeneron, Biogen, CAR-T, Valeant Pharmaceuticals, gene therapy, Theranos, Incyte, Afrezza
9 Biotech Picks for 2016
Barron's
Sat, 01/2/16 - 10:19 am
Tags:
biotech, Adaptimmune, Dermira, FibroGen, Incyte, Intra-Cellular Therapies, Seres Therapeutics, Ophthotech, Neurocrine Biosciences, Paratek
How Gilead Sciences M&A Can Pan Out Next Year
Bidness, ETC
Tue, 12/29/15 - 09:36 am
Tags:
Gilead Sciences, M&A, Vertex Pharmaceuticals, Incyte, Biomarin, Regeneron
Merck, Incyte eye a winning cancer combo with widened collaboration
Fierce Biotech
Tue, 10/13/15 - 09:57 am
Tags:
Merck, Incyte, cancer, Keytruda, epacadostat
10 Best Nasdaq Biotech Stocks in the Third Quarter
TheStreet.com
Wed, 09/30/15 - 07:49 pm
Tags:
Incyte, Myriad, Cara Therapeutics, Sucampo, ZS Pharma, Concert Pharmaceuticals, The Medicines Company, Lexicon Pharmaceuticals, Exelixis, Anacor
Lilly, Incyte rheumatoid arthritis drug succeeds in late-stage study
Yahoo/Reuters
Tue, 09/29/15 - 09:14 am
Tags:
Eli Lilly, Incyte, rheumatoid arthritis, baricitinib
Could These 2 Biopharmas Be the Real Apples of Gilead Sciences' Eye?
Motley Fool
Thu, 09/17/15 - 10:00 am
Tags:
Gilead Sciences, Baxalta, Incyte, M&A
Incyte Hits High On Cancer Drug Data, Buyout Talk
Investors.com
Fri, 09/11/15 - 05:56 pm
Tags:
Incyte, M&A, epacadostat, Yervoy, melanoma, Bristol-Myers Squibb
Incyte Named 7th Most Innovative Company in the World by Forbes Magazine
Yahoo
Fri, 08/21/15 - 10:12 am
Tags:
Incyte, innovation
Incyte beats Street 2Q forecasts
Yahoo/AP
Tue, 08/4/15 - 06:09 pm
Tags:
Incyte, earnings
What Will Gilead Buy Next? 4 Possible Targets
Investors.com
Wed, 07/15/15 - 06:30 pm
Tags:
Gilead Sciences, M&A, Incyte, Vertex Pharmaceuticals, Bristol-Myers Squibb, Achillion
ASCO '15: CTI Biopharma Takes on Myelofibrosis Drug Rival
TheStreet.com
Sat, 05/30/15 - 05:44 pm
Tags:
ASCO, CTI BioPharma, myelofibrosis, pacritinib, Jakafi, Incyte
Biotech: Asco Giveth, Asco Taketh Away
Barron's
Fri, 05/15/15 - 09:28 am
Tags:
ASCO, biotech, Amgen, Gilead Sciences, Puma Biotechnology, Incyte, Celgene
Why These 4 Biotech Stocks Could Be the Next Buyout Targets
24/7 Wall St
Thu, 05/7/15 - 09:23 am
Tags:
biotech, M&A, Biomarin, Bluebird Bio, Incyte, Vertex Pharmaceuticals
Incyte is opening an R&D command center in Geneva
Fierce Biotech
Tue, 04/14/15 - 09:50 am
Tags:
Incyte, R&D, Geneva
The Biotech Selloff: It’s Déjà Vu All Over Again
Barron's
Thu, 03/26/15 - 10:13 am
Tags:
biotech, Alnylam, Biomarin, Incyte, Isis Pharmaceuticals, Vertex Pharmaceuticals
Biotech pros' top 8 stock picks
Fortune
Mon, 03/9/15 - 11:59 am
Tags:
biotech, Bluebird Bio, Chimerix, Puma Biotechnology, Incyte, Isis Pharmaceuticals, Celgene, Alexion, Regeneron
The Next 3 Likely Biotech Buyout Candidates
24/7 Wall St
Fri, 03/6/15 - 08:38 am
Tags:
biotech, Biomarin, Bluebird Bio, Incyte, M&A
Incyte, Agenus partner on immuno-oncology targets in $410M deal
Fierce Biotech
Fri, 01/9/15 - 09:56 am
Tags:
Incyte, Agenus, immuno-oncology

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.